We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$1.1B
AUM Growth
+$42.2M
Cap. Flow
+$12.2M
Cap. Flow %
1.11%
Top 10 Hldgs %
33.6%
Holding
243
New
14
Increased
122
Reduced
64
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$10.2M
2
MDT icon
Medtronic
MDT
+$8.87M
3
SO icon
Southern Company
SO
+$5.12M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$3.51M
5
WMT icon
Walmart Inc
WMT
+$2.33M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$10.3M
2
CCI icon
Crown Castle
CCI
+$8.95M
3
AMGN icon
Amgen
AMGN
+$4.4M
4
VOD icon
Vodafone
VOD
+$2.5M
5
TRV icon
Travelers Companies
TRV
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Industrials 8.04%
3 Energy 7.64%
4 Consumer Staples 7.19%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
101
Abbott
ABT
$175B
$1.35M 0.12%
16,084
+584
+4% +$46K
BX icon
102
Blackstone
BX
$155B
$1.33M 0.12%
29,877
+3,751
+14% +$150K
DWM icon
103
WisdomTree International Equity Fund
DWM
$665M
$1.33M 0.12%
25,999
+276
+1% +$14K
AGG icon
104
iShares Core US Aggregate Bond ETF
AGG
$139B
$1.29M 0.12%
11,574
+10
+0.1% +$1.09K
IGSB icon
105
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$1.26M 0.11%
23,602
-1,069
-4% -$56.5K
MCD icon
106
McDonald's
MCD
$190B
$1.24M 0.11%
5,955
-60
-1% -$11.9K
V icon
107
Visa
V
$682B
$1.19M 0.11%
6,875
-47
-0.7% -$7.7K
BSX icon
108
Boston Scientific
BSX
$65.4B
$1.16M 0.11%
26,924
– –
DTD icon
109
WisdomTree US Total Dividend Fund
DTD
$1.64B
$1.14M 0.1%
23,450
-100
-0.4% -$4.79K
COST icon
110
Costco
COST
$417B
$1.14M 0.1%
4,307
+1
+0% +$249
EMR icon
111
Emerson Electric
EMR
$78.2B
$1.11M 0.1%
16,637
+63
+0.4% +$4.22K
HD icon
112
Home Depot
HD
$338B
$1.04M 0.09%
4,992
+22
+0.4% +$4.39K
NFLX icon
113
Netflix
NFLX
$290B
$982K 0.09%
26,740
– –
LMT icon
114
Lockheed Martin
LMT
$117B
$978K 0.09%
2,690
-6
-0.2% -$2.01K
NTNX icon
115
Nutanix
NTNX
$14.9B
$932K 0.08%
35,922
+2,324
+7% +$81K
BMY icon
116
Bristol-Myers Squibb
BMY
$124B
$887K 0.08%
19,567
+45
+0.2% +$2.1K
INOV
117
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$871K 0.08%
60,000
– –
LLY icon
118
Eli Lilly
LLY
$1.05T
$866K 0.08%
7,814
-1,616
-17% -$190K
SYK icon
119
Stryker
SYK
$123B
$845K 0.08%
4,112
-81
-2% -$15.5K
GE icon
120
GE Aerospace
GE
$364B
$844K 0.08%
16,125
+188
+1% +$9.25K
ITW icon
121
Illinois Tool Works
ITW
$79.4B
$824K 0.07%
5,466
+57
+1% +$8.61K
BPL
122
DELISTED
Buckeye Partners, L.P.
BPL
$820K 0.07%
19,967
+356
+2% +$13.4K
GD icon
123
General Dynamics
GD
$99.7B
$770K 0.07%
4,237
+44
+1% +$7.57K
GSK icon
124
GSK
GSK
$104B
$767K 0.07%
+15,322
New +$769K
DRI icon
125
Darden Restaurants
DRI
$22.7B
$730K 0.07%
5,994
– –
3 4
5
6 7

Similar funds

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

GW & Wade's Q2 2019 Portfolio in Review

As of Q2 2019, GW & Wade held 243 positions worth $1.1B, up 4% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

GW & Wade's Q2 2019 filing shows 14 new, 122 increased, 64 reduced and 9 closed positions. Its largest new stake was GSK: 15,322 shares worth $767K. The largest sale was 3M, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

  • GW & Wade's largest Q2 2019 buy was GSK: 15,322 shares worth $767K.
  • GW & Wade added most to Pfizer in Q2 2019, an estimated $10.2M increase.
  • GW & Wade's biggest Q2 2019 reduction was 3M, cutting an estimated $10.3M.
  • GW & Wade fully exited Crown Castle in Q2 2019, selling an estimated $8.95M.
  • GW & Wade's ten largest holdings make up 34% of its $1.1B portfolio in Q2 2019.
  • GW & Wade opened 14 new positions and closed 9 in Q2 2019.
  • GW & Wade's portfolio value rose 4% quarter-over-quarter to $1.1B.

Based on GW & Wade's 13F filing for Q2 2019, filed 12 Aug 2019.